FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to medicine, namely to pharmacology, and can be used in cell technologies. 7-(2-hydroxyethyl)theophylline is used as an agent stimulating colony-forming capacity of mesenchymal progenitor cells.
EFFECT: use of the given invention enables in vitro stimulation of colony-forming capacity of mesenchymal progenitor cells, increase the number of fibroblast colonies containing both committed stromal mesenchymal progenitor cells and multipotent mesenchymal stem cells.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STIMULATING GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2017 |
|
RU2665818C1 |
| METHOD FOR STIMULATING THE PRODUCTION OF NEUROTROPHIC GROWTH FACTORS BY NEUROGLIAL CELLS IN VITRO | 2022 |
|
RU2793910C1 |
| HEMOPROTECTIVE AGENT | 2019 |
|
RU2725135C1 |
| HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
| METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOETIN BY BONE MARROW CELLS IN VITRO | 2016 |
|
RU2628882C1 |
| METHOD FOR STIMULATION OF ERYTHROPOIETIN PRODUCTION BY BONE MARROW CELLS IN VITRO | 2019 |
|
RU2713122C1 |
| METHOD FOR STIMULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2020 |
|
RU2741784C1 |
| METHOD FOR STIMULATING PRODUCTION OF GRANULOCYTE COLONY-STIMULATING FACTOR BY BONE MARROW CELLS IN VITRO | 2021 |
|
RU2770784C1 |
| TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
| HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
